{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:21:52Z","timestamp":1794565312105,"version":"4.9.1"},"reference-count":15,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2016,5]]},"abstract":"ABSTRACT<\/jats:title>\n \n A retrospective analysis was performed using The Surveillance Network, USA, to examine the prevalence of antibiotic resistance among urine isolates from U.S. female outpatients in 2012 and assessed trends in antibiotic resistance comparing data from 2003 and 2012. The most common pathogen identified in 2012 (\n n<\/jats:italic>\n = 285,325) was\n Escherichia coli<\/jats:named-content>\n (64.9% of isolates). In 2012,\n E. coli<\/jats:named-content>\n resistance to nitrofurantoin was low (<3%) across all age groups.\n E. coli<\/jats:named-content>\n resistance to ciprofloxacin was high among adults (11.8%) and elderly outpatients (29.1%). When comparing the 2003 and 2012 data from isolates from adults,\n E. coli<\/jats:named-content>\n resistance to nitrofurantoin changed only slightly (from 0.7% to 0.9%), whereas increases in resistance to ciprofloxacin (3.6% to 11.8%) and trimethoprim-sulfamethoxazole (17.2% to 22.2%) changed substantially. In the United States,\n E. coli<\/jats:named-content>\n has become increasingly resistant to ciprofloxacin and trimethoprim-sulfamethoxazole (TMP-SMX) in adult female outpatients. Nitrofurantoin retains high levels of antibiotic activity against urinary\n E. coli<\/jats:named-content>\n .\n <\/jats:p>","DOI":"10.1128\/aac.02897-15","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T03:49:32Z","timestamp":1455680972000},"page":"2680-2683","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":146,"title":["Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012"],"prefix":"10.1128","volume":"60","author":[{"given":"Guillermo V.","family":"Sanchez","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Emory University School of Medicine, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Babiker","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Providence Hospital, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Master","sequence":"additional","affiliation":[{"name":"Quest Diagnostics Nichols Institute, Chantilly, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Luu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Southern California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Mathur","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Providence Hospital, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Bordon","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Providence Hospital, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c2096"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2010.190"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq257"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.12842"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/383029"},{"key":"e_1_3_2_7_2","volume-title":"CLSI M100-S21","author":"Clinical and Laboratory Standards Institute","year":"2011","unstructured":"Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-014-0659-4"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.6.635"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/511866"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt301"},{"key":"e_1_3_2_12_2","volume-title":"Critically important antimicrobials for human medicine","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. 2011. Critically important antimicrobials for human medicine, 3rd rev. World Health Organization, Geneva, Switzerland.","edition":"3"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02176-12"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2014.04.007"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1016\/S0002-9343(02)01060-4","article-title":"Urinary tract infection at the age extremes: pediatrics and geriatrics","volume":"113","author":"Shortliffe LM","year":"2002","unstructured":"Shortliffe LM, McCue JD. 2002. Urinary tract infection at the age extremes: pediatrics and geriatrics. Am J Med 113(Suppl 1A):55S\u201366S.","journal-title":"Am J Med"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.303"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02897-15","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02897-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:47:17Z","timestamp":1645476437000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02897-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1128\/AAC.02897-15"],"URL":"https:\/\/doi.org\/10.1128\/aac.02897-15","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"2015-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-01-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}